Bioventus Shares Jump 13% After Medicare Reversal

Bioventus Shares Jump 13% After Medicare Reversal

Bioventus Inc. (ticker BVS) saw its shares climb as much as 13% on Monday, reaching the highest intraday price level recorded since 2024. The price surge coincided with an announcement from the Centers for Medicare & Medicaid Services (CMS) that it had reversed previously issued reimbursement cuts affecting the company’s non‑invasive bone growth stimulators. During the same trading session, the BVS ticker posted a gain of 12.74%, indicating strong market optimism that the restored Medicare payments will benefit the company’s revenue stream.